portfolio execut continu leverag improv
post solid oper beat guidanc rais high end indic
roughli linear ep quarterli year view bake
conservat conting often earn edg bit rate
still strong quarter earn growth tax reform
oper organ order rose msd includ headwind larg
power busi order organ emg organ order rose
organ support view solid compound organ growth
difficult comparison continu expect fcf/ni
consist long-term convers rate
ep beat in-lin estim
guidanc sale core acq fx vs
estim ep guidanc revis vs prior
y-o-i sale low-doubl digit prior core mid-
sale grew y-o-i core acq fx om
bp y-o-i bp organ vs estim emg sale
grew y-o-i core acq fx round om
contract bp bp organ y-o-i vs bp estim
ep guidanc compar prior
consensu sale msd core record backlog
order growth organ organ book bill
announc acquisit soundcom system design
integr instal support clinic workflow commun system
healthcare/educational/corpor facil annual sale
spent deal ytd note current liquid
rais ep
pt remain target /share given sustain
compound model highli probabl acquir prospect solid return
high fcf/ni convers strong backlog underwrit outlook
analyst certif import disclosur see disclosur
expect posit investor sentiment
attent focus improv order trend longer cycl
process aerospac market project turn posit
consist histori oper improv expect
meaning leverag volum recoveri deal flow remain
solid robust recent deal play well oper
strong convers capit alloc prospect
cyclic lift and/or metal market
pent-up capit spend come
time organ improv
pace global econom activ remain slack
inabl execut integr acquisit expect
pt base /share given sustain compound model highli probabl acquir
prospect solid return high fcf/ni convers strong backlog underwrit outlook pt impli potenti upsid
includ dividend yield
risk includ weaker global growth includ us weak aerospac oil/gas/chem market inabl
complete/integr acquisit given relianc acquisit supplement top line inabl pass along higher raw materi cost
price aggress consensu ep estim time could hinder stock price perform
exhibit segment result varianc oppenheim estim
compani report oppenheim co inc estim
report ep vs year ago beat in-lin estim
guidanc revenu increas organ acquisit fx
vs estim order increas y-o-i report end
record backlog
segment oper margin expand bp y-o-i match estim
consolid basi oper margin rose bp y-o-i core bp y-o-i match
estim
flow/liquid repres /ni capital-expenditure total
vs full-year guid total debt off-set cash result net debt/
capit vs last year
guidanc manag rais ep guidanc vs prior y-
o-i sale outlook low-doubl digit vs prior organ sale mid-singl digit
prior continu expect full-year tax rate capital-expenditure depreci
amort guid ep vs prior consensu
sale organ mid-singl digit
compani report oppenheim co inc estim
electron instrument revenu increas y-o-i organ acquisit
fx round beat estim aerospac grew low-teen y-o-i msd organ
process increas hsd organ power industri grew y-o-i msd organ oper
margin expand bp y-o-i core bp y-o-i edg estim
electromechan revenu grew y-o-i organ acquisit
fx round beat estim engin solut organ sale
increas low-doubl digit core oper margin contract bp y-o-i core bp y-
o-i shi estim
annual sale profit segment
compani report oppenheim co inc
quarterli sale profit segment
compani report oppenheim co inc
analysi oper
segment revenu
total segment revenu
segment profit
total segment profit
compani report oppenheim co inc
year end decemb million
good sold
oper profit g/w charg
compani report oppenheim co inc
sale
oper profit g/w charg
compani report oppenheim co inc
year end decemb million
equival
intang invest asset
short-term borrow current portion ltd
average day inventori day hand
compani report oppenheim co inc
consolid statement flow
year end decemb million
inventori current asset
payabl accrual incom tax
net chang work capit
addit pp
proce sale asset discontinu op
purchas busi net cash
net chang short-term borrow
reduct long-term borrow
repurchas common stock
excess tax benefit share-bas payment
proce employe stock option
increas dec
equival -b
equival -e
compani report oppenheim co inc
